513 related articles for article (PubMed ID: 11882313)
21. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
22. Fluvastatin enhances apoptosis in cytokine-stimulated vascular smooth muscle cells.
Takahashi M; Ogata Y; Okazaki H; Takeuchi K; Kobayashi E; Ikeda U; Shimada K
J Cardiovasc Pharmacol; 2002 Feb; 39(2):310-7. PubMed ID: 11791017
[TBL] [Abstract][Full Text] [Related]
23. The mechanism underlying vascular smooth muscle cell apoptosis induced by atorvastatin may be mainly associated with down-regulation of survivin expression.
Xu YG; Zhou SH; Li YG; Zheng CH; Li XP; Liu QM; Xu DM; Chen S
Cardiovasc Drugs Ther; 2007 Jun; 21(3):145-53. PubMed ID: 17372815
[TBL] [Abstract][Full Text] [Related]
24. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c.
Ghavami S; Mutawe MM; Hauff K; Stelmack GL; Schaafsma D; Sharma P; McNeill KD; Hynes TS; Kung SK; Unruh H; Klonisch T; Hatch GM; Los M; Halayko AJ
Biochim Biophys Acta; 2010 Apr; 1803(4):452-67. PubMed ID: 20045437
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.
Tesfamariam B; Frohlich BH; Gregg RE
J Cardiovasc Pharmacol; 1999 Jul; 34(1):95-101. PubMed ID: 10413074
[TBL] [Abstract][Full Text] [Related]
26. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
Dechend R; Gieffers J; Dietz R; Joerres A; Rupp J; Luft FC; Maass M
Circulation; 2003 Jul; 108(3):261-5. PubMed ID: 12860900
[TBL] [Abstract][Full Text] [Related]
27. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
29. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
[TBL] [Abstract][Full Text] [Related]
30. Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.
Rodríguez-Vita J; Sánchez-Galán E; Santamaría B; Sánchez-López E; Rodrigues-Díez R; Blanco-Colio LM; Egido J; Ortiz A; Ruiz-Ortega M
PLoS One; 2008; 3(12):e3959. PubMed ID: 19088845
[TBL] [Abstract][Full Text] [Related]
31. Statins induce differentiation and cell death in neurons and astroglia.
März P; Otten U; Miserez AR
Glia; 2007 Jan; 55(1):1-12. PubMed ID: 16998865
[TBL] [Abstract][Full Text] [Related]
32. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
33. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity.
Xiao H; Qin X; Ping D; Zuo K
PLoS One; 2013; 8(3):e59233. PubMed ID: 23555637
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells.
Ali OF; Growcott EJ; Butrous GS; Wharton J
Respir Res; 2011 Oct; 12(1):137. PubMed ID: 21999923
[TBL] [Abstract][Full Text] [Related]
36. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
37. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
38. Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells.
Baetta R; Donetti E; Comparato C; Calore M; Rossi A; Teruzzi C; Paoletti R; Fumagalli R; Soma MR
Pharmacol Res; 1997 Aug; 36(2):115-21. PubMed ID: 9344639
[TBL] [Abstract][Full Text] [Related]
39. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
Kolyada AY; Fedtsov A; Madias NE
Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis.
Brinkkoetter PT; Gottmann U; Schulte J; van der Woude FJ; Braun C; Yard BA
Clin Exp Immunol; 2006 Dec; 146(3):524-32. PubMed ID: 17100774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
